Mpox Awareness Stays Low Among U.S. Adults

Less than half of survey respondents know a mpox vaccine exists, so check with your doctor about vaccination if you are at higher risk.

Updated on Nov. 22, 2026 in Diseases — General

Mpox Awareness Stays Low Among U.S. Adults

Live Poll

Do you know a mpox vaccine exists?

A Annenberg Public Policy Center survey concluded in October found that public awareness of mpox remains low across the United States, with less than half of respondents aware that a mpox vaccine exists. Familiarity with key transmission and isolation facts is uneven, which matters for adults deciding whether they or their family are at increased risk.

Why it matters

Low awareness can delay recognition of symptoms, vaccination decisions and safe-isolation practices, especially among people at higher risk. The survey also shows some public-health messages have gained ground while others have slipped since 2024.

The Annenberg Public Policy Center survey measured public knowledge of mpox facts across respondents, with awareness figures compared against a July 2024 baseline and a figure from two years earlier. Only the reported percentages are available here, so the survey's sample size and methodology should be checked against the Center's own release.

The players

Annenberg Public Policy Center

A University of Pennsylvania research center that conducts national surveys on public health and policy questions.

Centers for Disease Control and Prevention

The U.S. federal agency responsible for tracking infectious disease outbreaks and issuing vaccination and isolation guidance.

The details

Mpox is not an airborne disease and typically requires close, skin-to-skin contact to spread, and the virus was confirmed to spread through sex in 2022. The Centers for Disease Control and Prevention recommends the two-dose JYNNEOS vaccine for people at increased risk of monkeypox, and people with mpox are advised to isolate at home until the rash is gone.

Timeline

  1. 1958: mpox was first identified by scientists in monkeys.

  2. 2022: the virus was confirmed to spread through sex, with outbreaks in more than 70 countries.

  3. July 2024: awareness of placenta transmission was measured at 21%.

  4. October 2025: the Annenberg survey concluded.

  5. As of October: the CDC has reported more than 200 clade I mpox cases in at least 31 states and Puerto Rico.

Health Landscape

The survey adds to a multi-year record of U.S. mpox awareness tracking that began after the 2022 outbreaks spread through sex across more than 70 countries. Mpox was first identified in monkeys in 1958, and the current gap between awareness of vaccination and of transmission risk reflects how public-health attention to the disease has shifted since 2022.

Adults at higher risk of mpox may want to ask a clinician whether the two-dose JYNNEOS vaccine is appropriate for them. Anyone with a rash that could be mpox should isolate at home until it is gone and contact a healthcare provider.

The takeaway

Public awareness of mpox remains low, but isolation guidance has become more widely known since 2024. Ask a doctor whether vaccination is appropriate if you are in a group at increased risk.

Further reading

For broader context on infectious disease trends, explore Diseases — General.

Source note: This article includes information reported by Audacy.

Live Poll

Do you know a mpox vaccine exists?